We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
AUM
$325M
AUM Growth
+$52.5M
Cap. Flow
+$35.2M
Cap. Flow %
10.82%
Top 10 Hldgs %
40.31%
Holding
496
New
51
Increased
123
Reduced
128
Closed
48
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WU icon
426
Western Union
WU
$2.21B
$2K ﹤0.01%
99
-40
-29% -$868
LUMN icon
427
Lumen
LUMN
$6.47B
$1K ﹤0.01%
116
OXY icon
428
Occidental Petroleum
OXY
$55.2B
$1K ﹤0.01%
56
-1,000
-95% -$13.7K
PSQ icon
429
ProShares Short QQQ
PSQ
$722M
$1K ﹤0.01%
13
TLRY icon
430
Tilray
TLRY
$618M
$1K ﹤0.01%
7
-12
-63% -$875
RAD
431
DELISTED
Rite Aid Corporation
RAD
$1K ﹤0.01%
50
CDK
432
DELISTED
CDK Global, Inc.
CDK
$1K ﹤0.01%
10
ACB
433
Aurora Cannabis
ACB
$187M
$0 ﹤0.01%
4
AFL icon
434
Aflac
AFL
$63B
-174
Closed -$6K
AL
435
DELISTED
Air Lease Corp
AL
-31
Closed -$1K
ASIX icon
436
AdvanSix
ASIX
$428M
$0 ﹤0.01%
24
+12
+100% +$206
BAC.PRL icon
437
Bank of America Series L
BAC.PRL
$3.98B
-20
Closed -$30K
BTI icon
438
British American Tobacco
BTI
$129B
-3,121
Closed -$113K
CCEP icon
439
Coca-Cola Europacific Partners
CCEP
$47.7B
-5,000
Closed -$194K
CHKP icon
440
Check Point Software Technologies
CHKP
$12.9B
-9
Closed -$1K
CI icon
441
Cigna
CI
$73.6B
-4
Closed -$1K
CMP icon
442
Compass Minerals
CMP
$1.13B
-112
Closed -$7K
CNX icon
443
CNX Resources
CNX
$5.18B
$0 ﹤0.01%
25
CRTO icon
444
Criteo S.A. Ordinary Shares
CRTO
$903M
-42
Closed -$1K
DGX icon
445
Quest Diagnostics
DGX
$26.3B
-1,416
Closed -$2K
DINO icon
446
HF Sinclair
DINO
$14.3B
-20
Closed
DXC icon
447
DXC Technology
DXC
$1.75B
$0 ﹤0.01%
5
EFA icon
448
iShares MSCI EAFE ETF
EFA
$80.3B
-26
Closed -$1.78K
EW icon
449
Edwards Lifesciences
EW
$51.3B
-27
Closed -$2K
EWJ icon
450
iShares MSCI Japan ETF
EWJ
$22.9B
-31
Closed -$2K

Similar funds

Vectors Research Management's Q4 2020 Portfolio in Review

As of Q4 2020, Vectors Research Management held 496 positions worth $325M, up 19% from $273M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Vectors Research Management deployed $35.2M of net new capital in Q4 2020, opening 51 new positions and adding to 123 existing holdings. Its largest new stake was Xylem: 2,003 shares worth $204K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $4.25M trimmed.

  • Vectors Research Management's largest Q4 2020 buy was Xylem: 2,003 shares worth $204K.
  • Vectors Research Management added most to iShares 0-5 Year High Yield Corporate Bond ETF in Q4 2020, an estimated $6.49M increase.
  • Vectors Research Management's biggest Q4 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $4.25M.
  • Vectors Research Management fully exited Coca-Cola Europacific Partners in Q4 2020, selling an estimated $194K.
  • Vectors Research Management's ten largest holdings make up 40% of its $325M portfolio in Q4 2020.
  • Vectors Research Management opened 51 new positions and closed 48 in Q4 2020.
  • Vectors Research Management's portfolio value rose 19% quarter-over-quarter to $325M.

Based on Vectors Research Management's 13F filing for Q4 2020, filed 9 Feb 2021.